The Human Insulin market is expected to grow from USD 18.6 billion in 2022 to USD 39.4 Billion by 2032, at a CAGR of 7.80% during the forecast period 2023-2032.
Human insulin is the term used to refer to laboratory-grown insulin that imitates the insulin produced by the human body. Human insulin is the synthetic insulin produced in the laboratory to simulate human insulin. After developing in the 1960s to 70s, it was finally approved for medical purposes in 1982. The only benefit of human insulin is that it can be produced very cheaply. Human biosynthetic insulin has more acceptable purity than animal insulin, thereby reducing antibody formation. Human insulin is introduced into plants by some researchers to figure out a new style of producing insulin (biopharming) in safflower.
The driving factors of the market growth are rising cases of diabetes and formulation advancements. Regardless, the growing medication of drugs such as GLP-1 RAs to treat type 2 diabetes can slow market growth. It is an oligopolistic space dominated by Sanofi, Eli Lilly and Company, and Novo Nordisk A/S. Diabetes is one of the fast-rising chronic diseases globally. Its majority has grown slowly over the past few years. The WHO estimates that 537 million adults globally will be affected by diabetes in 2021, and one in ten experienced other diabetes.
This study delivers a comprehensive analysis of product, diabetes type, and region. The product segment includes traditional human insulin, and analogue insulin. The analogue insulin segment holds the largest market share in 2022 due to analog insulin has a better commitment to therapy and glycemic control. In expansion, it does not pose as much risk of hypoglycaemia as traditional products. In addition, according to Diabetes.co.uk, analogue insulins are fast and uniformly acting types of insulin. The diabetes type segment includes type1 diabetes, and type 2 diabetes. The type1 diabetes segment holds the largest market share in 2022 due to the rising majority of diabetes & daily need for insulin injections to control blood glucose levels in type 1 diabetes patients.
The market has been divided into North America, Europe, Asia-Pacific, Middle East & Africa, and South America. North America holds the largest market share due to the rising majority of type 1 diabetes drives North America's insulin drug market. For example, as per American Diabetes Association (ADA), 1.6 million Americans have type-1 diabetes, including 187,000 children and adolescents. Similarly, the growing price of insulin in the United States in the past decade has helped the North American market to push a considerable portion of the entire market.
Some of the notable players in the market are Biocon Ltd, Boehringer Ingelheim International GmbH, Eli Lilly and Company, Novo Nordisk A/S, Sanofi, and Wockhardt.
Report Description:
1. Introduction
1.1. Objectives of the Study
1.2. Market Definition
1.3. Research Scope
1.4. Currency
1.5. Key Target Audience
2. Research Methodology and Assumptions
3. Executive Summary
4. Premium Insights
4.1. Porter’s Five Forces Analysis
4.2. Value Chain Analysis
4.3. Top Investment Pockets
4.3.1. Market Attractiveness Analysis by Product
4.3.2. Market Attractiveness Analysis by Diabetes Type
4.3.3. Market Attractiveness Analysis by Region
4.4. Industry Trends
5. Market Dynamics
5.1. Market Evaluation
5.2. Drivers
5.2.1. Increasing Prevalence of Diabetes to Augment Market Growth
5.3. Restraints
5.3.1. Human insulin results in side effects such as tiredness, and an increase in weight
5.4. Opportunities
5.4.1. Technological Advancement
6. Global Human Insulin Market Analysis and Forecast, By Product:
6.1. Segment Overview
6.2. Traditional Human Insulin
6.3. Analogue Insulin
7. Global Human Insulin Market Analysis and Forecast, By Diabetes Type
7.1. Segment Overview
7.2. Type1 Diabetes
7.3. Type 2 Diabetes
8. Global Human Insulin Market Analysis and Forecast, By Regional Analysis
8.1. Segment Overview
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.2.3. Mexico
8.3. Europe
8.3.1. Germany
8.3.2. France
8.3.3. U.K.
8.3.4. Italy
8.3.5. Spain
8.4. Asia-Pacific
8.4.1. Japan
8.4.2. China
8.4.3. India
8.5. South America
8.5.1. Brazil
8.6. Middle East and Africa
8.6.1. UAE
8.6.2. South Africa
9. Global Human Insulin Market-Competitive Landscape
9.1. Overview
9.2. Market Share of Key Players in the Human Insulin Market
9.2.1. Global Company Market Share
9.2.2. North America Company Market Share
9.2.3. Europe Company Market Share
9.2.4. APAC Company Market Share
9.3. Competitive Situations and Trends
9.3.1. Product Launches and Developments
9.3.2. Partnerships, Collaborations, and Agreements
9.3.3. Mergers & Acquisitions
9.3.4. Expansions
10. Company Profiles
10.1. Biocon Ltd.
10.1.1. Business Overview
10.1.2. Company Snapshot
10.1.3. Company Market Share Analysis
10.1.4. Company Product Portfolio
10.1.5. Recent Developments
10.1.6. SWOT Analysis
10.2. Boehringer Ingelheim International GmbH
10.2.1. Business Overview
10.2.2. Company Snapshot
10.2.3. Company Market Share Analysis
10.2.4. Company Product Portfolio
10.2.5. Recent Developments
10.2.6. SWOT Analysis
10.3. Eli Lilly and Company
10.3.1. Business Overview
10.3.2. Company Snapshot
10.3.3. Company Market Share Analysis
10.3.4. Company Product Portfolio
10.3.5. Recent Developments
10.3.6. SWOT Analysis
10.4. Novo Nordisk A/S
10.4.1. Business Overview
10.4.2. Company Snapshot
10.4.3. Company Market Share Analysis
10.4.4. Company Product Portfolio
10.4.5. Recent Developments
10.4.6. SWOT Analysis
10.5. Sanofi.
10.5.1. Business Overview
10.5.2. Company Snapshot
10.5.3. Company Market Share Analysis
10.5.4. Company Product Portfolio
10.5.5. Recent Developments
10.5.6. SWOT Analysis
10.6. Wockhardt.
10.6.1. Business Overview
10.6.2. Company Snapshot
10.6.3. Company Market Share Analysis
10.6.4. Company Product Portfolio
10.6.5. Recent Developments
10.6.6. SWOT Analysis
List of Table
1. Global Human Insulin Market, By Product, 2019-2032 (USD Billion)
2. Global Traditional Human Insulin Human Insulin Market, By Region, 2019-2032 (USD Billion)
3. Global Analogue Insulin Human Insulin Market, By Region, 2019-2032 (USD Billion)
4. Global Human Insulin Market, By Diabetes Type, 2019-2032 (USD Billion)
5. Global Type1 Diabetes Human Insulin Market, By Region, 2019-2032 (USD Billion)
6. Global Type 2 Diabetes Human Insulin Market, By Region, 2019-2032 (USD Billion)
7. North America Human Insulin Market, By Product, 2019-2032 (USD Billion)
8. North America Human Insulin Market, By Diabetes Type, 2019-2032 (USD Billion)
9. U.S. Human Insulin Market, By Product, 2019-2032 (USD Billion)
10. U.S. Human Insulin Market, By Diabetes Type, 2019-2032 (USD Billion)
11. Canada Human Insulin Market, By Product, 2019-2032 (USD Billion)
12. Canada Human Insulin Market, By Diabetes Type, 2019-2032 (USD Billion)
13. Mexico Human Insulin Market, By Product, 2019-2032 (USD Billion)
14. Mexico Human Insulin Market, By Diabetes Type, 2019-2032 (USD Billion)
15. Europe Human Insulin Market, By Product, 2019-2032 (USD Billion)
16. Europe Human Insulin Market, By Diabetes Type, 2019-2032 (USD Billion)
17. Germany Human Insulin Market, By Product, 2019-2032 (USD Billion)
18. Germany Human Insulin Market, By Diabetes Type, 2019-2032 (USD Billion)
19. France Human Insulin Market, By Product 2019-2032 (USD Billion)
20. France Human Insulin Market, By Diabetes Type, 2019-2032 (USD Billion)
21. U.K. Human Insulin Market, By Product, 2019-2032 (USD Billion)
22. U.K. Human Insulin Market, By Diabetes Type, 2019-2032 (USD Billion)
23. Italy Human Insulin Market, By Product, 2019-2032 (USD Billion)
24. Italy Human Insulin Market, By Diabetes Type, 2019-2032 (USD Billion)
25. Spain Human Insulin Market, By Product, 2019-2032 (USD Billion)
26. Spain Human Insulin Market, By Diabetes Type, 2019-2032 (USD Billion)
27. Asia Pacific Human Insulin Market, By Product, 2019-2032 (USD Billion)
28. Asia Pacific Human Insulin Market, By Diabetes Type, 2019-2032 (USD Billion)
29. Japan Human Insulin Market, By Product, 2019-2032 (USD Billion)
30. Japan Human Insulin Market, By Diabetes Type, 2019-2032 (USD Billion)
31. China Human Insulin Market, By Product 2019-2032 (USD Billion)
32. China Human Insulin Market, By Diabetes Type, 2019-2032 (USD Billion)
33. India Human Insulin Market, By Product 2019-2032 (USD Billion)
34. India Human Insulin Market, By Diabetes Type, 2019-2032 (USD Billion)
35. South America Human Insulin Market, By Product, 2019-2032 (USD Billion)
36. South America Human Insulin Market, By Diabetes Type, 2019-2032 (USD Billion)
37. Brazil Human Insulin Market, By Product 2019-2032 (USD Billion)
38. Brazil Human Insulin Market, By Diabetes Type, 2019-2032 (USD Billion)
39. Middle East and Africa Human Insulin Market, By Product, 2019-2032 (USD Billion)
40. Middle East and Africa Human Insulin Market, By Diabetes Type, 2019-2032 (USD Billion)
41. UAE Human Insulin Market, By Product, 2019-2032 (USD Billion)
42. UAE Human Insulin Market, By Diabetes Type, 2019-2032 (USD Billion)
43. South Africa Human Insulin Market, By Product 2019-2032 (USD Billion)
44. South Africa Human Insulin Market, By Diabetes Type, 2019-2032 (USD Billion)
List of Figures
1. Global Human Insulin Market Segmentation
2. Human Insulin Market: Research Methodology
3. Market Size Estimation Methodology: Bottom-Up Approach
4. Market Size Estimation Methodology: Top-Down Approach
5. Data Triangulation
6. Porter’s Five Forces Analysis
7. Value Chain Analysis
8. Global Human Insulin Market Attractiveness Analysis by Product
9. Global Human Insulin Market Attractiveness Analysis by Diabetes Type
10. Global Human Insulin Market Attractiveness Analysis by Region
11. Global Human Insulin Market: Dynamics
12. Global Human Insulin Market Share by Product (2022 & 2032)
13. Global Human Insulin Market Share by Diabetes Type (2022 & 2032)
14. Global Human Insulin Market Share by Regions (2022 & 2032)
15. Global Human Insulin Market Share by Company (2022)
Market research is a method of gathering, assessing and deducing data & information about a particular market. Market research is very crucial in these days. The techniques analyze about how a product/service can be offered to the market to its end-customers, observe the impact of that product/service based on the past customer experiences, and cater their needs and demands. Owing to the successful business ventures, accurate, relevant and thorough information is the base for all the organizations because market research report/study offers specific market related data & information about the industry growth prospects, perspective of the existing customers, and the overall market scenario prevailed in past, ongoing present and developing future. It allows the stakeholders and investors to determine the probability of a business before committing substantial resources to the venture. Market research helps in solving the marketing issues challenges that a business will most likely face.
Market research is valuable because of the following reasons:
Our research report features both the aspects; qualitative and quantitative. Qualitative part provides insights about the market driving forces, potential opportunities, customer’s demands and requirement which in turn help the companies to come up with new strategies in order to survive in the long run competition. The quantitative segment offers the most credible information related to the industry. Based on the data gathering, we use to derive the market size and estimate their future growth prospects on the basis of global, region and country.
Our market research process involves with the four specific stages.
Data Collection: This stage of the market research process involves with the gathering and collecting of the market/industry related data from the sources. There are basically two types of research methods:
Data Synthesis: This stage includes the evaluation and assessment of all the data acquired from the primary and secondary research. It likewise includes in evaluating the information for any disparity watched while information gathering identified with the market. The data & information is gathered with consideration to the heterogeneity of sources. Scientific and statistical methods are implemented for synthesizing dissimilar information sets and provide the relevant data which is fundamental for formulating strategies. Our organization has broad involvement with information amalgamation where the information goes through different stages:
Market Formulation & Deduction: The last stage includes assigning the data & information in a suitable way in order to derive market size. Analyst reviews and domain based opinions based on holistic approach of market estimation combined with industry investigation additionally features a crucial role in this stage.
This stage includes with the finalization of the market size and numbers that we have gathered from primary and secondary research. With the data & information addition, we ensure that there is no gap in the market information. Market trend analysis is finished by our analysts by utilizing data extrapolation procedures, which give the most ideal figures to the market.
Data Validation: Validation is the most crucial step in the process. Validation & re-validation through scientifically designed technique and process that helps us finalize data-points to be used for final calculations. This stage also involves with the data triangulation process. Data triangulation generally implicates the cross validation and matching the data which has been collected from primary and secondary research methods.
Free Customization
Countries can be added on demand
Free yearly update on purchase of Multi/Corporate User License
Companies served till date
We serve our customers 24x7 for 365 days through calls, emails and live chat options.
Huge database of exceptional market reports bringing market intelligence to your fingertips.
SSL enabled, we offer you various secured payment options for risk free purchase.